Parosanu, A.I.; Baston, C.; Stanciu, I.M.; Parlog, C.F.; Nitipir, C.
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers. Diagnostics 2023, 13, 2430.
https://doi.org/10.3390/diagnostics13142430
AMA Style
Parosanu AI, Baston C, Stanciu IM, Parlog CF, Nitipir C.
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers. Diagnostics. 2023; 13(14):2430.
https://doi.org/10.3390/diagnostics13142430
Chicago/Turabian Style
Parosanu, Andreea Ioana, Catalin Baston, Ioana Miruna Stanciu, Cristina Florina Parlog, and Cornelia Nitipir.
2023. "Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers" Diagnostics 13, no. 14: 2430.
https://doi.org/10.3390/diagnostics13142430
APA Style
Parosanu, A. I., Baston, C., Stanciu, I. M., Parlog, C. F., & Nitipir, C.
(2023). Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers. Diagnostics, 13(14), 2430.
https://doi.org/10.3390/diagnostics13142430